Non-steroidal Anti-inflammatory Drugs and Colorectal Cancer Prevention

Overview

Journal Postgrad Med J

Publisher Oxford University Press

Specialty General Medicine

Date 2005 Apr 7

PMID 15811884

Citations 7

Authors

S Sangha

M Yao

M M Wolfe

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer is the second leading cause of cancer deaths in the United States. Currently, the most effective strategy available for colon cancer prevention is endoscopic screening, with polypectomy or surgical resection for advanced lesions. This intervention carries with it many concerns regarding cost, patient acceptance, and the growing burden of surveillance colonoscopies for patients with polyps. Further improvements in the understanding of the multistep model of colorectal carcinogenesis will probably lead to the development of other primary and secondary prevention strategies. Data obtained from animal and epidemiological studies and most recently from randomised, placebo controlled trials, suggest that non-steroidal anti-inflammatory drugs may prove effective chemopreventive agents in different groups of people, from patients with familial adenomatous polyposis to those with sporadic adenomas.

Citing Articles

Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents.

Aputen A, Elias M, Gilbert J, Sakoff J, Gordon C, Scott K Cancers (Basel). 2023; 15(9).

PMID: 37173934 PMC: 10177380. DOI: 10.3390/cancers15092460.

Unboxing the molecular modalities of mutagens in cancer.

Kumari S, Sharma S, Advani D, Khosla A, Kumar P, Ambasta R Environ Sci Pollut Res Int. 2021; 29(41):62111-62159.

PMID: 34611806 PMC: 8492102. DOI: 10.1007/s11356-021-16726-w.

The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.

Luo C, Zhang H Mediators Inflamm. 2017; 2017:5126048.

PMID: 28852270 PMC: 5568615. DOI: 10.1155/2017/5126048.

Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention.

Aboul-Fadl T, Al-Hamad S, Lee K, Li N, Gary B, Keeton A Med Chem Res. 2016; 23(9):4177-4188.

PMID: 27559271 PMC: 4993210. DOI: 10.1007/s00044-014-0979-z.

The role of hypoxia in inflammatory disease (review).

Biddlestone J, Bandarra D, Rocha S Int J Mol Med. 2015; 35(4):859-69.

PMID: 25625467 PMC: 4356629. DOI: 10.3892/ijmm.2015.2079.

References

Su L, Kinzler K, Vogelstein B, Preisinger A, Moser A, Luongo C . Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science. 1992; 256(5057):668-70. DOI: 10.1126/science.1350108. View

Phillips R, Wallace M, Lynch P, Hawk E, Gordon G, Saunders B . A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut. 2002; 50(6):857-60. PMC: 1773237. DOI: 10.1136/gut.50.6.857. View

Giovannucci E, Stampfer M, Colditz G, Rimm E, Trichopoulos D, Rosner B . Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst. 1993; 85(11):875-84. DOI: 10.1093/jnci/85.11.875. View

Gann P, Manson J, Glynn R, Buring J, Hennekens C . Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst. 1993; 85(15):1220-4. DOI: 10.1093/jnci/85.15.1220. View

Nugent K, Farmer K, Spigelman A, Williams C, Phillips R . Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg. 1993; 80(12):1618-9. DOI: 10.1002/bjs.1800801244. View

Giovannucci E, Rimm E, Stampfer M, Colditz G, Ascherio A, Willett W . Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994; 121(4):241-6. DOI: 10.7326/0003-4819-121-4-199408150-00001. View

Levy D, Smith K, Hamilton S, Vogelstein B, Kinzler K . Inactivation of both APC alleles in human and mouse tumors. Cancer Res. 1994; 54(22):5953-8. View

Debinski H, Trojan J, Nugent K, Spigelman A, Phillips R . Effect of sulindac on small polyps in familial adenomatous polyposis. Lancet. 1995; 345(8953):855-6. View

Kargman S, ONeill G, Vickers P, Evans J, Mancini J, Jothy S . Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 1995; 55(12):2556-9. View

10.

Giovannucci E, Egan K, Hunter D, Stampfer M, Colditz G, Willett W . Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995; 333(10):609-14. DOI: 10.1056/NEJM199509073331001. View

11.

Reddy B, Rao C, Seibert K . Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 1996; 56(20):4566-9. View

12.

Oshima M, Dinchuk J, Kargman S, Oshima H, Hancock B, Kwong E . Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996; 87(5):803-9. DOI: 10.1016/s0092-8674(00)81988-1. View

13.

Gregg X, Reddy V, Prchal J . Copper deficiency masquerading as myelodysplastic syndrome. Blood. 2002; 100(4):1493-5. DOI: 10.1182/blood-2002-01-0256. View

14.

Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M . Cancer statistics, 2003. CA Cancer J Clin. 2003; 53(1):5-26. DOI: 10.3322/canjclin.53.1.5. View

15.

Imperiale T . Aspirin and the prevention of colorectal cancer. N Engl J Med. 2003; 348(10):879-80. DOI: 10.1056/NEJMp030005. View

16.

Sandler R, Halabi S, Baron J, Budinger S, Paskett E, Keresztes R . A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003; 348(10):883-90. DOI: 10.1056/NEJMoa021633. View

17.

Baron J, Cole B, Sandler R, Haile R, Ahnen D, Bresalier R . A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003; 348(10):891-9. DOI: 10.1056/NEJMoa021735. View

18.

Lynch H, de la Chapelle A . Hereditary colorectal cancer. N Engl J Med. 2003; 348(10):919-32. DOI: 10.1056/NEJMra012242. View

19.

Bush A . The metallobiology of Alzheimer's disease. Trends Neurosci. 2003; 26(4):207-14. DOI: 10.1016/S0166-2236(03)00067-5. View

20.

Ritchie C, Bush A, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L . Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol. 2003; 60(12):1685-91. DOI: 10.1001/archneur.60.12.1685. View